Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

JSE/CLS stock hub

JSE/CLS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JSE/CLSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

61.8B

Johannesburg Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

JSE/CLS

In the news

Latest news · JSE/CLS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.1

P25 11.2P50 16.2P75 17.1

Trailing P/E18.7

P25 6.4P50 15.9P75 23.4

ROE53.3

P25 -14P50 7.2P75 31.6

ROIC38.1

P25 9.2P50 15.3P75 38.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JSE/CLS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

ZAR

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	ZA
Employees	20,682
Employees Change	580%
Employees Change Percent	2.89
Enterprise value	ZAc 65B
Exchange	Johannesburg Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	ZAE000134854
Last refreshed	2026-05-10
Market cap	ZAc 61.8B
Price	ZAc 26,429
Price currency	ZAc
Rev Per Employee	2,395,127.16x
Sector	Healthcare
Sic	5990
Symbol	jse/CLS
Website	https://www.clicksgroup.co.za

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.39%
EV Earnings	19.51x
EV/EBIT	13.47x
EV/EBITDA	9.76x
EV/FCF	15.35x
EV/Sales	1.31x
FCF yield	6.85%
Forward P/E	17.06x
P/B ratio	10.13x
P/E ratio	18.7x
P/S ratio	1.25x
PE Ratio10 Y	28.78x
PE Ratio3 Y	27.29x
PE Ratio5 Y	27.52x
PEG ratio	1.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.74%
EBITDA Margin	11.14%
FCF margin	8.55%
Gross margin	23.54%
Gross Profit	ZAc 11.7B
Gross Profit Growth	2.28%
Gross Profit Growth Q	4.67%
Gross Profit Growth3 Y	3.12%
Gross Profit Growth5 Y	4.59%
Net Income	ZAc 3.3B
Net Income Growth	11.01%
Net Income Growth Q	6.6%
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Net Income Growth3 Y	5.5%
Net Income Growth5 Y	5.59%
Pretax Margin	9.2%
Profit Margin	6.72%
Profit Per Employee	ZAc 161,058
Profitable Years	21
ROA	13.8
Roa5y	12.46
ROCE	51.82
ROE	53.34
Roe5y	45.52
ROIC	38.06
Roic5y	41.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.36%
Cagr15y	15.37%
Cagr1y	-30.74%
Cagr20y	20.56%
Cagr3y	2.42%
Cagr5y	3.62%
Div CAGR10	13.95%
Div CAGR3	12.17%
Div CAGR5	8.86%
EPS Growth	12.15
EPS Growth Q	8.31
EPS Growth Quarters	5
EPS Growth Years	2
EPS Growth3 Y	5.9
EPS Growth5 Y	6.28
FCF Growth	13.89%
FCF Growth Q	-3.03%
FCF Growth3 Y	3.75%
FCF Growth5 Y	1.43%
OCF Growth	17.5%
OCF Growth Q	6.66%
OCF Growth10 Y	8.24%
OCF Growth3 Y	4.26%
OCF Growth5 Y	1.72%
Revenue Growth	5.85x
Revenue Growth Q	7.37x
Revenue Growth Quarters	47x
Revenue Growth Years	23x
Revenue Growth3 Y	2.92x
Revenue Growth5 Y	3.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 2.27
Assets	ZAc 23B
Cash	ZAc 1.2B
Current Assets	ZAc 14.4B
Current Liabilities	ZAc 13.7B
Debt	ZAc 4.4B
Debt EBITDA	ZAc 0.66
Debt Equity	ZAc 0.72
Debt FCF	ZAc 1.04
Equity	ZAc 6.1B
Interest Coverage	12.55
Liabilities	ZAc 16.9B
Long Term Assets	ZAc 8.6B
Long Term Liabilities	ZAc 3.2B
Net Cash	ZAc -3.2B
Net Cash By Market Cap	ZAc -5.14
Net Debt EBITDA	ZAc 0.58
Net Debt Equity	ZAc 0.52
Net Debt FCF	ZAc 0.75
Tangible Book Value	ZAc 4.9B
Tangible Book Value Per Share	ZAc 21.02
WACC	5.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.05
Inventory Turnover	4.46
Net Working Capital	ZAc 909.5M
Quick ratio	0.39
Working Capital	ZAc 722M
Working Capital Turnover	ZAc 46.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.02%
Dividend Growth	12.69%
Dividend Growth Years	3%
Dividend per share	ZAc 8.86
Dividend Years	31
Dividend Yield	3.35%
Ex Div Date	2026-07-01
Last Dividend	ZAc 2.58
Payout Frequency	Semi-Annual
Payout Ratio	62.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	220.66%
1Y total return	-30.72%
200-day SMA	33,708
3Y total return	7.43%
50-day SMA	29,109.6
50-day SMA vs 200-day SMA	50under200
5Y total return	19.48%
All Time High	40,539
All Time High Change	-34.81%
All Time High Date	2024-11-25
All Time Low	296
All Time Low Change	8,828.72%
All Time Low Date	1996-09-03
ATR	861.8
Beta	0.17
Beta1y	0.31
Beta2y	0.27
Ch YTD	-21.48
High	27,010
High52	39,499
High52 Date	2025-06-05
High52ch	-33.09%
Low	26,187
Low52	25,847
Low52 Date	2026-05-05
Low52ch	2.25%
Ma50ch	-9.21%
Price vs 200-day SMA	-21.59%
RSI	34.83
RSI Monthly	34.81
RSI Weekly	24.23
Sharpe ratio	-1.71x
Sortino ratio	-1.9
Total Return	4.37%
Tr YTD	-20
Tr15y	754.42%
Tr1m	-9.44%
Tr1w	1.46%
Tr3m	-18.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc 4.8B
Operating Income Growth	3.33
Operating Income Growth Q	7.43
Operating Income Growth3 Y	5
Operating Income Growth5 Y	5.85
Operating margin	9.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	233,662,139%
Net Borrowing	-1,117,045,000
Shares Insiders	0.08%
Shares Institutions	75.07%
Shares Out	233,851,000
Shares Qo Q	-1.12%
Shares Yo Y	-1.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ZAc 4.2B
Average Volume	1,015,827.9x
Bv Per Share	26.05
CAPEX	ZAc -1.1B
Ch10y	160.9
Ch15y	504.9
Ch1m	-9.44
Ch1w	1.46
Ch1y	-32.43
Ch20y	2,417
Ch3m	-18.83
Ch3y	0.1
Ch5y	6.97
Ch6m	-26.18
Change	-0.57%
Change From Open	0.11
Close	26,580
Days Gap	-0.68
Depreciation Amortization	691,868,000
Dollar Volume	23,100,082,447
Earnings Date	2026-04-23
EBIT	ZAc 4.8B
EBITDA	ZAc 5.5B
EPS	ZAc 14.14
F Score	5
FCF	ZAc 4.2B
FCF EV Yield	6.51x
FCF Per Share	ZAc 18.1
Financing CF	-4,700,065,000
Fiscal Year End	August
Founded	1,968
Goodwill	240,381,000
Graham Number	9142.02857
Graham Upside	-65.41
Income Tax	ZAc 1.2B
Investing CF	-1,092,911,000
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-02-28
Lynch Fair Value	ZAc 7,966
Lynch Upside	-69.86
Ma150	32,656.3
Ma150ch	-19.07%
Ma20	28,055.1
Ma20ch	-5.8%
Net CF	-486,213,000
Next Earnings Date	2026-07-21
Open	26,400
P FCF Ratio	14.6
P OCF Ratio	11.65
Payment Date	2026-07-06
Position In Range	29.4
Ppne	6,930,224,000
Price Date	2026-05-08
Price EBITDA	ZAc 11.2
Ptbv Ratio	12.57
Relative Volume	0.86x
Revenue	49,536,020,000x
Tax By Revenue	2.47x
Tax Rate	26.87%
Tr20y	4,110.19%
Tr6m	-24.79%
Volume	874,043
Z Score	6.19

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

JSE/CLS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$8.86 annual per share

Payout ratio

+62.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.9%

3 consecutive years of growth

Total shareholder yield

+4.4%

Next ex-dividend date: 2026-07-01

Performance

JSE/CLS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JSE/CLS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+75.1%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.0%

Negative means the company is buying back shares.

Technical

JSE/CLS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.8

Neutral momentum band

Price vs 200-day MA

-21.6%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

-1.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JSE/CLS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current jse/CLS stock rating?

jse/CLS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full jse/CLS analysis?

The full report lives at /stocks/jse/CLS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for jse/CLS?

The latest report frames jse/CLS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the jse/CLS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.